Please login to your online account to display your discounted pricing

anti-Ornithine Decarboxylase, Clone: ODC1/485, Novus Biologicals™


Manufacturer: novus biologicals canada  NBP2328871ML

 View more versions of this product

 Disclaimers

For Research Use Only

Catalog No. NBP2328871M

  • / Each
 

Description & Specifications

Specifications

Host Species Mouse
Applications ELISA
Applications Flow Cytometry
Applications Immunocytochemistry
Applications Immunofluorescence
Applications Immunohistochemistry (Frozen)
Applications Immunohistochemistry (Paraffin)
Applications Immunoprecipitation
Applications Western Blotting
Isotype κ
Quantity 1mL
Clone ODC1/485
Formulation PBS with 0.05% BSA.
Regulatory Status RUO
Gene Accession No. P11926
Primary or Secondary Primary
Conjugate Unlabeled
Monoclonal or Polyclonal Monoclonal
Gene ID (Entrez) 4953
Test Specificity Recognizes a 53kDa protein, identified as the Ornithine Decarboxylase (ODC-1). ODC is the initial and rate-limiting enzyme in the biosynthetic pathway of polyamines and is involved in the conversion of ornithine to putrescine. The biological activity of ODC-1 is rapidly induced in response to virtually all agents known to promote cell proliferation including hormones, drugs, growth factors, mitogens, and tumor promoters. Reportedly, ODC mRNA levels are elevated in lung carcinomas as well as in colon adenomas and carcinomas. ODC activity in colorectal carcinomas is greater than those in adenomas and normal mucosa.
Concentration 0.2mg/mL
Cross Reactivity Human
Immunogen Recombinant human ODC-1 protein
Format Purified
Antigen Ornithine Decarboxylase